We revealed that HNK suppresses the progression of NASH/NAFLD to HCC in mouse models by inducing the nuclear translocation of GR and subsequent induction of MIG6, a negative regulator of EGFR protein expression. Here, EGFR is linked to metabolic dysfunction-associated steatotic liver disease.